National health plan

Recent Articles

RELATED ARTICLES

  1. Earnings blow for CSPC Pharma
    Earnings blow for CSPC Pharma as the state drives a hard bargain
    1093.HK
  2. NEWS WRAP: Hutchmed sells non-core asset to focus on cancer treatment
    0013.HK HCM.US
  3. Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  4. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  5. BRIEF: Ascentage Pharma gets Chinese regulatory nod for U.S. listing
    6855.HK
  6. PegBio aims to bulk up its finances to deliver weight-loss drugs
  7. BRIEF: Ascentage Pharma prices U.S. IPO at 20% discount, to raise up to $130 million
    6855.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva